Anti-VASH1/ KIAA1036/ TTCP 1 functional antibody

Anti-VASH1/ KIAA1036/ TTCP 1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to VASH1/VASH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1359-Ab-1/ GM-Tg-hg-SE1359-Ab-2Anti-Human VASH1 monoclonal antibodyHuman
GM-Tg-rg-SE1359-Ab-1/ GM-Tg-rg-SE1359-Ab-2Anti-Rat VASH1 monoclonal antibodyRat
GM-Tg-mg-SE1359-Ab-1/ GM-Tg-mg-SE1359-Ab-2Anti-Mouse VASH1 monoclonal antibodyMouse
GM-Tg-cynog-SE1359-Ab-1/ GM-Tg-cynog-SE1359-Ab-2Anti-Cynomolgus/ Rhesus macaque VASH1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1359-Ab-1/ GM-Tg-felg-SE1359-Ab-2Anti-Feline VASH1 monoclonal antibodyFeline
GM-Tg-cang-SE1359-Ab-1/ GM-Tg-cang-SE1359-Ab-2Anti-Canine VASH1 monoclonal antibodyCanine
GM-Tg-bovg-SE1359-Ab-1/ GM-Tg-bovg-SE1359-Ab-2Anti-Bovine VASH1 monoclonal antibodyBovine
GM-Tg-equg-SE1359-Ab-1/ GM-Tg-equg-SE1359-Ab-2Anti-Equine VASH1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1359-Ab-1/ GM-Tg-hg-SE1359-Ab-2; GM-Tg-rg-SE1359-Ab-1/ GM-Tg-rg-SE1359-Ab-2;
GM-Tg-mg-SE1359-Ab-1/ GM-Tg-mg-SE1359-Ab-2; GM-Tg-cynog-SE1359-Ab-1/ GM-Tg-cynog-SE1359-Ab-2;
GM-Tg-felg-SE1359-Ab-1/ GM-Tg-felg-SE1359-Ab-2; GM-Tg-cang-SE1359-Ab-1/ GM-Tg-cang-SE1359-Ab-2;
GM-Tg-bovg-SE1359-Ab-1/ GM-Tg-bovg-SE1359-Ab-2; GM-Tg-equg-SE1359-Ab-1/ GM-Tg-equg-SE1359-Ab-2
Products NameAnti-VASH1 monoclonal antibody
Formatmab
Target NameVASH1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-VASH1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1359-Ag-1Recombinant multi-species VASH1/ KIAA1036/ TTCP 1 protein
    ORF Viral VectorvGMLP001438human VASH1 Lentivirus particle
    ORF Viral VectorpGMLP001438human VASH1 Lentivirus plasmid
    ORF Viral VectorpGMLPm001397mouse Vash1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001397mouse Vash1 Lentivirus particle


    Target information

    Target IDGM-SE1359
    Target NameVASH1
    Gene ID22846,238328,503052,703906,490799,101100138,615419,100051887
    Gene Symbol and SynonymsD930046M13Rik,G630009D10Rik,KIAA1036,RGD1564082,TTCP 1,VASH1
    Uniprot AccessionQ7L8A9
    Uniprot Entry NameVASH1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000071246
    Target ClassificationN/A

    The target: VASH1, gene name: VASH1, also named as KIAA1036, TTCP 1. Enables actin binding activity and metallocarboxypeptidase activity. Involved in negative regulation of angiogenesis; negative regulation of blood vessel endothelial cell migration; and proteolysis. Acts upstream of or within several processes, including negative regulation of endothelial cell migration; negative regulation of endothelial cell proliferation; and negative regulation of lymphangiogenesis. Located in apical part of cell; endoplasmic reticulum; and extracellular space. Implicated in liver cirrhosis and portal hypertension. Biomarker of liver cirrhosis. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.